• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY I HIV AG/AB COMBO REAGENT KIT; TEST, HIV DETECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY I HIV AG/AB COMBO REAGENT KIT; TEST, HIV DETECTION Back to Search Results
Catalog Number 08P07-32
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/05/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.No further information was provided.
 
Event Description
The customer obtained (b)(6) alinity i (b)(6) combo results for one patient.Sample id (b)(6) generated (b)(6) results of (b)(6) on the alinity and (b)(6) on nat assay.No impact to patient management was reported.
 
Event Description
The customer obtained false non-reactive alinity i hiv ag/ab combo results for one patient.Sample id (b)(6) generated non-reactive results of 0.1, 0.130 and 0.130 s/co on the alinity and positive on nat assay.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review and inhouse testing of a retained kit of the complaint lot number.Return testing was not completed as returns were not available.Review of trending reports did not identify and trends associated with the issue.Device history record review for the reagent lot did not identify any non-conformances or deviations related to the complaint issue.Inhouse testing of a retained kit of reagent lot 22259be00 determined that the sensitivity performance of the complaint lot was not negatively impacted.Two commercially available seroconversion panels were tested with the complaint lot.The lot showed results comparable to the data provided by the manufacturer of the panels.Based on our investigation, no systemic issue or deficiency of alinity i hiv ag/ab combo reagent, lot number 22259be00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I HIV AG/AB COMBO REAGENT KIT
Type of Device
TEST, HIV DETECTION
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key11076492
MDR Text Key243766496
Report Number3002809144-2020-01210
Device Sequence Number1
Product Code MZF
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 02/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/08/2021
Device Catalogue Number08P07-32
Device Lot Number22259BE00
Was Device Available for Evaluation? No
Date Manufacturer Received01/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, AI02957; ALNTY I PROCESSING MODU, 03R65-01, AI02957
-
-